Cupid jumps on starting development programme for Nitrile Female Condom
Cupid is currently trading at Rs. 80.30, up by 1.55 points or 1.97% from its previous closing of Rs. 78.75 on the BSE.
The scrip opened at Rs. 80.50 and has touched a high and low of Rs. 81.00 and Rs. 79.00 respectively. So far 392328 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 105.48 on 02-Jan-2026 and a 52 week low of Rs. 10.00 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs. 91.95 and Rs. 74.60 respectively. The current market cap of the company is Rs. 10878.31 crore.
The promoters holding in the company stood at 45.55%, while Institutions and Non-Institutions held 1.74% and 52.71% respectively.
Cupid has commenced development programme for a Nitrile (NBR) Female Condom, a strategic initiative aimed at entering and diversifying the currently single supplier global nitrile female condom market. With the increasing demand from global procurement agencies for supply diversification, the company’s entry into nitrile female condom manufacturing represents a significant strategic opportunity.
The company’s new manufacturing facility has been architecturally and technically designed to accommodate dual-polymer dipping lines operating concurrently. This configuration allows the facility to manufacture Natural Rubber Latex (NRL) condoms and Nitrile Butadiene Rubber (NBR) condoms on dedicated production lines within the same facility, ensuring no cross-contamination and optimal production efficiency. With this development, the company becomes the only condom manufacturer in India with integrated dualpolymer dipping capability, enabling the company to serve the established NRL male condom market, the NRL female condom market and the premium nitrile female condom segment. Upon full commissioning, the expanded new facility is expected to support annual production capacity of around 1.25 billion male condoms and 125 million female condoms.
The company has initiated a structured research and development programme for the nitrile female condom, supported by international technical expertise with deep domain experience in NBR compound formulation, dipping technology and female condom design engineering. The programme will focus on formulation optimization, coagulant engineering, dipping parameters, and comprehensive validation testing, in accordance with ISO 25841:2017 standards for female condoms. The company already possesses a strong regulatory foundation in the segment, with its NRL-based female condom currently holding WHO/UNFPA prequalification and being supplied to more than 50 countries globall
